We are live on
!
Find out more
CCP
Cryder Capital Partners Portfolio holdings
AUM
$1.53B
1-Year Est. Return
9.36%
This Fund
S&P 500
This Quarter
Est. Return
+14.07%
1 Year Est. Return
+9.36%
3 Year Est. Return
+71.2%
5 Year Est. Return
+84.02%
10 Year Est. Return
+425.03%
AUM
$882M
AUM Growth
+$103M
(+13%)
Cap. Flow
-$4.82M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$4.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 40.04% |
| 2 | Healthcare | 29.7% |
| 3 | Financials | 18.66% |
| 4 | Technology | 11.6% |
Similar funds
HR
SG
FBB
FI
MCP
CCM
AF
ICM
Cryder Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Cryder Capital Partners held 9 positions worth $882M, up 13% from $779M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 0%. Cryder Capital Partners opened no new positions and made no exits, leaving the 9-position portfolio largely intact.
By sector, the portfolio is most concentrated in Communication Services at 40% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.
- Cryder Capital Partners's biggest Q4 2019 reduction was Thermo Fisher Scientific, cutting an estimated $4.82M.
- Cryder Capital Partners's ten largest holdings make up 100% of its $882M portfolio in Q4 2019.
- Cryder Capital Partners opened 0 new positions and closed 0 in Q4 2019.
- Cryder Capital Partners's portfolio value rose 13% quarter-over-quarter to $882M.
Based on Cryder Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.